five of 11 normotensive patients with congestive heart failure responded to an infusion of the specific angiotensin ii antagonist , saralasin , by reducing systemic vascular resistance from 2274 +/- 418 to 1690 +/- 351 dynes/sec/cm-5 ( mean +/- standard error ) .
C0003009
angiotensin ii
C0036193
saralasin